Download PDF
Horm Metab Res 2017; 49(08): 604-611
DOI: 10.1055/s-0043-109561
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Measuring VLDL1-Triglyceride and VLDL2-Triglyceride Kinetics in Men: Effects of Dietary Control on Day-to-Day Variability

Rakel Fuglsang Johansen
1   Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark
,
Esben Søndergaard
1   Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark
2   The Danish Diabetes Academy, Odense, Denmark
,
Lars Peter Sørensen
1   Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark
,
Anne Grethe Jurik
3   Department of Radiology, Aarhus University Hospital, Aarhus C, Denmark
,
Søren Nielsen
1   Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark
› Author Affiliations
Further Information

Publication History

received 11 January 2017

accepted 10 April 2017

Publication Date:
30 May 2017 (online)

Also available at
    Permissions and Reprints

Abstract

The aim of this study was to assess the impact of dietary control on VLDL1- and VLDL2-TG kinetics and associated metabolic parameters. Twelve overweight/obese men were randomized to a provided 3 day isocaloric diet with fixed macronutrient composition (diet group, n=6) or to their regular unrestricted diet (non-diet group, n=6). VLDL1- and VLDL2-TG turnovers were measured twice 2–4 weeks apart, using primed-constant infusion of ex vivo labeled [1-14C]VLDL1-TG and [9,10-3H]VLDL2-TG. Isocaloric diet intervention lowered the difference in the mean of both VLDL2-TG secretion and clearance rate (p<0.01), and the coefficient of variation (CV) of VLDL2-TG clearance rate (p<0.05). The difference in mean and CV of the other kinetic estimates (VLDL1-TG secretion, clearance and oxidation rate) were lowered, but not significantly. The CV’s of total triglyceride, VLDL1-TG, and VLDL2-TG concentrations were significantly lowered by diet intervention compared to regular diet; total triglyceride (31%–5%, p<0.01), VLDL1-TG (42%–9%, p<0.01), and VLDL2-TG (36%–10%, p<0.01). In conclusion, VLDL1- and VLDL2-TG kinetics show great day-to-day variability, which may be diminished by diet intervention. Therefore, standardized macronutrient intake prior to study days improves the probability of demonstrating significant outcomes of cross-sectional and intervention studies of VLDL1-TG and VLDL2-TG kinetics and metabolism.

Key words

diet intervention - fatty acid/oxidation - human - triglycerides - VLDL kinetics

Supporting Information

    Supporting Information for this article is available online at http://www.thieme-connect.de/products
  • Supporting Information
 

  • References

  • 1 Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004; 89: 2601-2607
    CrossrefPubMedGoogle Scholar
  • 2 Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 1993; 91: 748-758
    CrossrefPubMedGoogle Scholar
  • 3 Adiels M, Packard C, Caslake MJ, Stewart P, Soro A, Westerbacka J, Wennberg B, Olofsson SO, Taskinen MR, Boren J. A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions. J Lipid Res 2005; 46: 58-67
    CrossrefPubMedGoogle Scholar
  • 4 Adiels M, Boren J, Caslake MJ, Stewart P, Soro A, Westerbacka J, Wennberg B, Olofsson SO, Packard C, Taskinen MR. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 2005; 25: 1697-1703
    CrossrefPubMedGoogle Scholar
  • 5 Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003; 46: 733-749
    CrossrefPubMedGoogle Scholar
  • 6 Gill JM, Brown JC, Bedford D, Wright DM, Cooney J, Hughes DA, Packard CJ, Caslake MJ. Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects. Atherosclerosis 2004; 176: 49-56
    CrossrefPubMedGoogle Scholar
  • 7 Johansen RF, Sondergaard E, Sorensen LP, Jurik AG, Christiansen JS, Nielsen S. Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes. Diabetologia 2016; 59: 833-843
    CrossrefPubMedGoogle Scholar
  • 8 Sidossis LS, Mittendorfer B, Walser E, Chinkes D, Wolfe RR. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol 1998; 275 5 Pt 1 E798-E805
    CrossrefPubMedGoogle Scholar
  • 9 Sidossis LS, Magkos F, Mittendorfer B, Wolfe RR. Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man. Clin Nutr 2004; 23: 457-466
    CrossrefPubMedGoogle Scholar
  • 10 Sorensen LP, Gormsen LC, Nielsen S. VLDL-TG kinetics: a dual isotope study for quantifying VLDL-TG pool size, production rates, and fractional oxidation in humans. Am J Physiol Endocrinol Metab 2009; 297: E1324-E1330
    CrossrefPubMedGoogle Scholar
  • 11 Magkos F, Patterson BW, Mittendorfer B. Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics. J Lipid Res 2007; 48: 1204-1211
    CrossrefPubMedGoogle Scholar
  • 12 Magkos F, Fabbrini E, Korenblat K, Okunade AL, Patterson BW, Klein S. Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease. Int J Obes (Lond) 2011; 35: 1233-1240
    CrossrefPubMedGoogle Scholar
  • 13 Magkos F, Patterson BW, Mittendorfer B. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Am J Physiol Endocrinol Metab 2006; 291: E1243-E1249
    CrossrefPubMedGoogle Scholar
  • 14 Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-1204
    CrossrefPubMedGoogle Scholar
  • 15 Jensen MD, Bajnarek J, Lee SY, Nielsen S, Koutsari C. Relationship between postabsorptive respiratory exchange ratio and plasma free fatty acid concentrations. J Lipid Res 2009; 50: 1863-1869
    CrossrefPubMedGoogle Scholar
  • 16 Nielsen S, Guo Z, Albu JB, Klein S, O’Brien PC, Jensen MD. Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest 2003; 111: 981-988
    CrossrefPubMedGoogle Scholar
  • 17 Adiels M, Olofsson SO, Taskinen MR, Boren J. Diabetic dyslipidaemia. Curr Opin Lipidol 2006; 17: 238-246
    CrossrefPubMedGoogle Scholar
  • 18 Redgrave TG, Carlson LA. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res 1979; 20: 217-229
    PubMedGoogle Scholar
  • 19 Lindgren FT, Jensen LC, Hatch FT. Quantitation, composition and metabolism. In: blood lipids and lipoproteins. New York: Wiley; 1972: 181-274
    Google Scholar
  • 20 Mills GL, Lane PA, Weech PK. The isolation and purification of plasma lipoproteins. In: A guidebook to lipoprotein technique. Amsterdam: Elsevier; 1984: 18-114
    Google Scholar
  • 21 Tong H, Knapp HR, VanRollins M. A low temperature flotation method to rapidly isolate lipoproteins from plasma. J Lipid Res 1998; 39: 1696-1704
    PubMedGoogle Scholar
  • 22 Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983; 55: 628-634
    CrossrefPubMedGoogle Scholar
  • 23 Sorensen LP, Sondergaard E, Nellemann B, Christiansen JS, Gormsen LC, Nielsen S. Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men. Diabetes 2011; 60: 2257-2264
    CrossrefPubMedGoogle Scholar
  • 24 Hopkins WG. Measures of reliability in sports medicine and science. Sports Med 2000; 30: 1-15
    CrossrefPubMedGoogle Scholar
  • 25 Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310
    PubMedGoogle Scholar
  • 26 Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest 2004; 113: 1582-1158
    CrossrefPubMedGoogle Scholar
  • 27 Goris AH, Westerterp KR. Postabsorptive respiratory quotient and food quotient-an analysis in lean and obese men and women. Eur J Clin Nutr 2000; 54: 546-550
    CrossrefPubMedGoogle Scholar
  • 28 Adiels M, Westerbacka J, Soro-Paavonen A, Hakkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-Jarvinen H, Taskinen MR, Boren J. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 2007; 50: 2356-2365
    CrossrefPubMedGoogle Scholar
  • 29 Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL ApoB production in normal weight and obese individuals. Diabetes 1993; 42: 833-842
    CrossrefPubMedGoogle Scholar